Annabelle Fonseca

Dr. Annabelle Fonseca


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Journal of Surgical Research
Verified
Journal Article
Closed access
AFAnnabelle Fonseca
Annabelle Fonseca
VRVikram Reddy
Vikram Reddy
WLWalter E. Longo
Walter E. Longo
RGRichard J. Gusberg
Richard J. Gusberg

1 May 2014 in The American Journal of Surgery
Verified
Journal Article
Closed access
AFAnnabelle Fonseca
Annabelle Fonseca
VRVikram Reddy
Vikram Reddy
WLWalter E. Longo
Walter E. Longo
RURobert Udelsman
Robert Udelsman
RGRichard J. Gusberg
Richard J. Gusberg

4 June 2014 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
AFAnnabelle Fonseca
Annabelle Fonseca
CCCharles H. Cha
Charles H. Cha

1 July 2015 in Journal of Surgical Education
Verified
Journal Article
Closed access
AFAnnabelle Fonseca
Annabelle Fonseca
VRVikram Reddy
Vikram Reddy
WLWalter E. Longo
Walter E. Longo
RGRichard J. Gusberg
Richard J. Gusberg

10 December 2013 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
AFAnnabelle Fonseca
Annabelle Fonseca
DODoruk E. Ozgediz
Doruk E. Ozgediz
ECEmily R. Christison-Lagay
Emily R. Christison-Lagay
FDFrank C. Detterbeck
Frank C. Detterbeck
MCMichael G. Caty
Michael G. Caty

5 August 2013 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
RKReju Korah
Reju Korah
JHJames Healy
James Healy
JKJohn W Kunstman
John W Kunstman
AFAnnabelle Fonseca
Annabelle Fonseca
AAAmir H Ameri
Amir H Ameri
TCTobias Carling
Tobias Carling
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with high mutational heterogeneity and a generally poor clinical outcome. Despite implicated roles of deregulated TP53, IGF-2 and Wnt signaling pathways, a clear genetic association or unique mutational link to the disease is still missing. Recent studies suggest a crucial role for epigenetic modifications in the genesis and/or progression of ACC. This study specifically evaluates the potential role of epigenetic silencing of RASSF1A, the most commonly silenced tumor suppressor gene, in adrenocortical malignancy.